Nevanac 3-Month Safety Study With QID Dosing
Clinical trial NCT00332774 · COMPLETED
Trial details
- NCT number
- NCT00332774
- Sponsor
- Alcon Research
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2006-12-01
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.